1. Home
  2. AQST vs DFP Comparison

AQST vs DFP Comparison

Compare AQST & DFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aquestive Therapeutics Inc.

AQST

Aquestive Therapeutics Inc.

HOLD

Current Price

$4.14

Market Cap

504.0M

Sector

Health Care

ML Signal

HOLD

Logo Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

DFP

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

HOLD

Current Price

$20.40

Market Cap

427.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
AQST
DFP
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
504.0M
427.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
AQST
DFP
Price
$4.14
$20.40
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$9.00
N/A
AVG Volume (30 Days)
1.6M
43.6K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
6.73%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$67,430,000.00
N/A
Revenue This Year
$10.08
N/A
Revenue Next Year
$49.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.77
N/A
52 Week Low
$2.38
$19.56
52 Week High
$7.55
$22.11

Technical Indicators

Market Signals
Indicator
AQST
DFP
Relative Strength Index (RSI) 47.82 37.04
Support Level $4.02 $19.56
Resistance Level $4.38 $21.35
Average True Range (ATR) 0.22 0.18
MACD -0.01 -0.08
Stochastic Oscillator 14.90 25.23

Price Performance

Historical Comparison
AQST
DFP

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About DFP Flaherty & Crumrine Dynamic Preferred and Income Fund Inc.

Flaherty & Crumrine Dynamic Preferred and Income Fund Inc is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.

Share on Social Networks: